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Abstract: We investigated the effects of polysaccharides from the brown seaweed 
Sargassum graminifolium (Turn.) (SGP) on calcium oxalate crystallization, and determined 
its antioxidant activities. To examine the effects of SGP on calcium oxalate crystallization, 
we monitored nucleation and aggregation of calcium oxalate monohydrate crystals, using 
trisodium citrate as a positive control. We assessed antioxidant activities of SGP by 
determining its reducing power, its ability to scavenge superoxide radicals, and its activity 
in the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay. The nucleation inhibition ratio of 
trisodium citrate and SGP was 58.5 and 69.2%, respectively, and crystal aggregation was 
inhibited by 71.4 and 76.8%, respectively. Increasing concentrations of SGP resulted in 
increased scavenging of superoxide anions and DPPH radicals (IC50 = 1.9 and 0.6 mg/mL, 
respectively). These results suggest that SGP could be a candidate for treating urinary stones 
because of its ability to inhibit calcium oxalate crystallization and its antioxidant properties. 
Keywords:  calcium oxalate crystallization; antioxidant; polysaccharide; Sargassum 
graminifolium 
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Abbreviations 
SGP, polysaccharide from Sargassum graminifolium; IR, infrared spectrum; DPPH, 1,1-diphenyl-2-
picrylhydrazyl free radical; Ox, oxalate; CaOx, calcium oxalate; OD, optical density; SN, maximum 
increase of optical density with time; SA, rate of aggregation derived from the maximum decrease in 
optical density; tmax, maximum time; COM, Calcium oxalate monohydrate; COD, Calcium oxalate 
dehydrate; COT, Calcium oxalate trihydrate. 
1. Introduction 
In recent years, there has been much interest in isolating novel bioactive compounds with beneficial 
effects on human health from marine resources. Marine algae are valuable sources of structurally 
diverse bioactive compounds. Sulfated polysaccharides are widespread in marine algae, especially 
brown seaweeds. Sulfated polysaccharides show various biological activities, including anticoagulant, 
antioxidant, antiviral, anticancer and immunomodulating activities [1–5]. Zhang et al. [6] reported that 
sulfated polysaccharides play important roles as free-radical scavengers and antioxidants, which can 
prevent oxidative damage in living organisms. The low molecular weight polysaccharides heparin and 
fucoidan provided protection against oxalate (Ox)-induced oxidative renal injury [3,7]. Ox and calcium 
oxalate monohydrate (COM) induce the generation of free radicals, which are major mediators of the 
pathologic consequences of the formation of kidney stones [8]. Hence, sulfated polysaccharides may 
be a potential candidate for treating urinary stones because of their protective role in Ox-mediated 
peroxidative injury. 
Urinary stones affect a large proportion of the population. Approximately 85% of urinary stones  
are calcium stones, which consist of Ox and phosphate, either alone or in combination [9,10]. 
Crystallization is a physical and chemical process in which there is a change of state from solution to 
solid. This involves several physicochemical events, i.e., nucleation, growth and aggregation, but the 
mechanisms controlling these events are not fully understood [11,12].  
It is widely known that urinary stones frequently reoccur, and despite progress in medical therapies, 
there is no satisfactory drug for treatment of this condition [13–15]. Recent research has shown that 
exposure of renal cells to high concentrations of Ox and/or calcium oxalate (CaOx) crystals leads to 
the production of reactive oxygen species (ROS) in tissue culture and animal model studies [16–18]. 
ROS play critical roles as signaling molecules; however, an overproduction of ROS and/or a reduction 
in cellular antioxidant capacities due to downregulation of antioxidant enzymes results in oxidative 
stress [19]. Some studies in vitro and in vivo showed that treatments with antioxidants and free-radical 
scavengers can reduce Ox/CaOx crystal-induced injuries [18,20]. Some well-known antioxidants, such 
as vitamin E, have shown promising effects in populations of recurrent stone-formers [21]. These 
results suggest that there is great potential for the therapeutic application of antioxidants and free-radical 
scavengers to reduce the occurrence and reoccurrence of urinary stones and to provide superior renal 
protection [22]. Since the conventional treatment methods vary in their effectiveness, it is worth 
searching for alternative treatments, e.g., different diets or medicinal plants [8,23] for the treatment of 
urinary stones. Mar. Drugs 2012, 10 121 
 
 
Brown seaweeds have been used in traditional Chinese medicine for more than 1000 years [24]. 
Sargassum graminifolium, a brown seaweed extensively distributed along the coasts of the South 
China Sea and the East China Sea, is commonly consumed as seafood, and as medical resource for its 
antiallergic effects [25]. To fully utilize this rich resource, it is meaningful to evaluate the 
polysaccharide bioactivity of S. graminifolium. The aim of the present study was to investigate the 
antioxidant properties of a polysaccharide extract from S. graminifolium, and to determine its ability to 
inhibit crystallization. These properties are useful attributes for compounds that could be used to treat 
urinary stones. 
2. Results and Discussion  
2.1. Properties of SGP 
The results show the total sugar content is 75.68%, protein content is 0.12% and sulfate is 10.13%. 
Figure 1 shows that SGP in 3471, 2900, 1648 and 1253 cm
−1 are absorption peaks, they are the 
stretching vibration of sugar ring O–H, C–H, C=O and S=O, so this result indicates the SGP contains 
high sulfate content and it is consistent with chemical analysis result. 
Figure 1. IR spectra of Sargassum graminifolium (Turn.) (SGP).  
 
2.2. Effect on Calcium Oxalate Crystallization 
The inhibitory effect of SGP and trisodium citrate on CaOx crystallization is shown in Table 1. At 
concentrations of 4 mmol/L calcium and 0.5 mmol/L Ox, addition of 0.25 mmol/L trisodium citrate  
or 0.01 g/100 mL SGP resulted in a nucleation percentage inhibition ratio of 58.5 and 69.2%, 
respectively, and crystal aggregation was inhibited by 71.4 and 76.8%, respectively. Compared with 
control conditions, both SGP and trisodium citrate significantly inhibited CaOx crystallization. As 
shown in Table 1, addition of both SGP and trisodium citrate resulted in increases in tmax and 
decreased slopes of CaOx crystal growth (SN and SA) (P < 0.05). Mar. Drugs 2012, 10 122 
 
 
Table 1. Effects of SGP on calcium oxalate crystallization. 
 
4 mmol/L calcium/ 
0.5 mmol/L 
oxalate 
4 mmol/L calcium/ 
0.5 mmol/L oxalate +  
0.25 mmol/L trisodium citrate 
4 mmol/L calcium/ 
0.5 mmol/L oxalate + 
0.01 g/100 mL SGP 
P 
tmax (min)  8.67 ± 0.94  13.44 ± 0.57  14.02 ± 0.82  P < 0.05 
a 
       P < 0.05 
b
SN (×10
−3/min)  5.30 ± 1.23  2.20 ± 0.36  1.63 ± 0.28  P < 0.05 
a 
       P < 0.05 
b
SA (×10
−3/min)  1.87 ± 0.62  0.53 ± 0.19  0.43 ± 0.05  P < 0.05 
a 
       P < 0.05 
b
a 4 mmol/L calcium/0.5 mmol/L oxalate compared with 4 mmol/L calcium/0.5 mmol/L oxalate + 0.25 mmol/L 
trisodium citrate; 
b 4 mmol/L calcium/0.5 mmol/L oxalate compared with 4 mmol/L calcium/0.5 mmol/L 
oxalate + 0.01 g/100 mL SGP. 
2.3. Effect on Crystal Morphology 
The amount of crystal formation, as estimated from the turbidity of the solution, is shown in Figure 2. 
Incubating solutions of Ca
2+ and Ox resulted in the formation of CaOx crystals (Figure 2A) that 
consisted largely of hexagonal COM. Both SGP (0.5 mg/mL) and trisodium citrate (1 mM) resulted in 
the shape changes of CaOx crystals, as shown in Figure 2B,C; a more rounded polygonal crystals 
shape. This shape may prevent the formation of kidney stones, because crystals with this shape are 
more easily excreted in the urine compared with the COM. 
Figure 2. The CaOx crystals, observed under inverted microscope (100×), formed in the 
metastable solution of CaOx in the absence (A) and the presence of (B) trisodium citrate  
(1 mM) (C) SGP (0.5 mg/mL). 
   
(A) (B) (C) 
Microphotography studies verified that SGP resulted in the formation of round CaOx crystals. 
CaOx develops in three different hydrated forms: COM, dehydrate (COD), and trihydrate (COT). 
COM is the most thermodynamically stable phase, followed by tetragonal COD and then triclinic 
COT. COM and COD are the major forms found in most urinary calculi [26,27]. SGP inhibited the 
growth of COM crystals, prevented the aggregation of COM crystals, and induced the formation of 
spherical COD crystals. These spherical COD crystals are the thermodynamically less stable phase and 
have weaker affinity for cell membranes than COM crystals [28]. Mar. Drugs 2012, 10 123 
 
 
2.4. Antioxidant Effects of SGP 
The antioxidant properties of SGP are shown in Figures 3–5. Superoxide anion radicals are formed 
in cellular oxidation reactions, and these radicals can result in the production of hydrogen peroxide and 
hydroxyl radicals through dismutation and other chemical reactions. Superoxide anions have a longer 
lifetime and can move over greater distances than other oxygen radicals; hence, they are more 
damaging [29]. Therefore, the ability to scavenge superoxide anions is an important biological 
property for a therapeutic compound. The superoxide anion scavenging activity of different 
concentrations of SGP is shown in Figure 3. The scavenging effects of SGP increased with increasing 
concentrations; the IC50 was 1.9 mg/mL. 
Figure 3. Scavenging of superoxide anion by various concentrations of SGP. 
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Figure 4. Scavenging of DPPH radical by various concentrations of SGP. 
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Figure 5. Reducing power of various concentrations of SGP. 
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The DPPH free radical is a stable free radical that is widely used as a tool for estimating the  
free-radical scavenging activities of antioxidants [30]. Free radicals are highly reactive species of 
atoms or molecules that are unstable because of single or unbalanced electrons. DPPH is a compound 
with a proton free radical that has a characteristic absorption. The absorption of a DPPH solution 
decreases significantly in the presence of proton radical scavengers. The scavenging of the DPPH free 
radical by antioxidants is due to their hydrogen-donating ability [31,32]. The DPPH radical scavenging 
ability of SGP is shown in Figure 4. The ability to scavenge the DPPH radical increased with 
increasing concentrations of SGP in a concentration-dependent manner. The IC50 was 0.6 mg/mL.  
Reducing power assays are used to evaluate the capacity of natural antioxidants to donate an 
electron. Natural antioxidants are believed to break free-radical chain reactions by donating an electron 
or hydrogen atom to free radicals. Therefore, the reducing power of a compound is a significant 
indicator of its potential antioxidant activity [33,34]. The reducing power of SGP is shown in Figure 5. 
At concentrations of 0.2, 0.4, 0.8, 1.6 and 3.2 mg/mL, the reducing power of SGP was 0.21, 0.37, 0.42, 
0.57 and 0.89, respectively. These results showed that SGP is able to donate electrons, which may be 
involved in its antioxidant activity. 
3. Experimental Section  
3.1. Chemicals and Reagents 
Dry  S. graminifolium (Turn.) was obtained from Zhuhai, Guangdong Province, China.   
1,1-Diphenyl-2-picrylhydrazyl (DPPH) was purchased from Sigma Chemical Co. (St. Louis, MO, 
USA). All other reagents were of analytical grade. 
3.2. Extraction of Polysaccharides from S. graminifolium and Its Properties 
The polysaccharide extract from S. graminifolium (SGP) was prepared as described by   
Zhuang et al. [35]. Briefly, crude polysaccharides were extracted from the powdered seaweed by 
chloroform extraction, boiling water extraction, and ethanol precipitation. The degreased seaweed Mar. Drugs 2012, 10 125 
 
 
powder was incubated in a water bath at 90 °C for 3 h, and the residue was re-extracted twice and then 
concentrated to one-third of the original volume at 80 °C, adding 95% ethanol to the water extract until 
the ethanol concentration reached 80%. After standing overnight, the mixture was centrifuged at 2775 g 
for 15 min. The precipitate containing crude polysaccharides was washed with 95% ethanol, then with 
ethyl ether, and finally with acetone. Proteins were removed by adding trichloroacetic acid and 
centrifuging the mixture at 2775 g for 15 min, then added some sodium hydroxide in the centrifuged 
solution, to neutralize the remained TCA, and took dialysis operation for it. The resulting products 
were concentrated and freeze-dried, then kept it in the refrigerator. 
To analyze the constituents of SGP 3 methods were used: the phenol sulfuric acid method for the 
determination of total sugar content, Folin-Phenol Determination method for protein content, and the 
barium sulfate turbidimetric method for sulfate content. Furthermore, functional groups of SGP were 
determined by infrared spectrum (IR). 
3.3. Calcium Oxalate Crystallization Assay  
The effect of SGR on CaOx crystallization was measured spectrophotometrically over 30 min at 
620 nm. This assay quantifies crystal nucleation and aggregation in metastable solutions of Ca
2+ and 
Ox. There are three parameters that characterize the crystallization process [36]: first, the maximum 
increase of optical density (OD) over time, termed SN, mainly reflects the maximum rate of formation 
of new particles and thus, represents crystal nucleation. Second, the rate of aggregation, SA, is derived 
from the maximum decrease in optical density. Third, the maximum time, tmax, is the time at which 
crystals can neither nucleate nor grow. All three parameters are measurable in the crystallization 
process of CaOx. 
We used linear regression analyses for slope measurements. The percentage inhibition was 
calculated from the nucleation and aggregation rates, as follows: [1 − (SNm/SNc)] × 100 for the rate of 
nucleation and [(1 − SAm/SAc)] × 100, for the rate of aggregation (where Sm is the slope in the presence 
of the test material and Sc is the slope of the control experiment). 
CaOx monohydrate crystallization was achieved using a mixture of calcium chloride (8 mmol/L) 
and sodium oxalate (1 mmol/L), containing 200 mmol/L sodium chloride and 10 mmol/L sodium 
acetate, adjusted to pH 5.7. The concentrations of compounds in this mixture are close to physiological 
urinary concentrations. The CaCl2 solution (1.0 mL) was stirred constantly at 37 °C both in the 
absence and presence of different concentrations of the test material or trisodium citrate as the positive 
control. After obtaining a stable base line, crystallization was induced by the addition of Na2C2O4 
solution (1.0 mL) to reach final concentrations of 4 mmol/L calcium and 0.5 mmol/L Ox. Modifiers of 
CaOx crystallization were compared in assays containing 4 mmol/L calcium and 0.5 mmol/L Ox. The 
change in turbidity over time was measured. All experiments were run in triplicate. 
3.4. Image Analysis of Crystal Morphology 
In this study, we used imaging techniques to observe the size and morphology of the crystals and to 
verify the effect of incubation with the test material on CaOx crystal formation. We used stock 
solutions of CaCl2 and Na2C2O4 with compositions similar to those in the kinetic study. Aliquots  
(0.5 mL) of CaCl2 solutions containing SGP (0.5 mg/mL) or trisodium citrate (1 mmol/L) were added Mar. Drugs 2012, 10 126 
 
 
to wells in a 24-well plate. To each of the wells, Na2C2O4 solution (0.5 mL) was added to obtain final 
concentrations of 4.25 mmol Ca
2+ and 0.75 mmol Ox [18]. Each concentration of the test material was 
prepared in triplicate. The plates were then incubated in a shaking water bath at 90 oscillations/min at 
37 °C for 45 min. Each well was then observed under an inverted microscope (Olympus Corporation, 
Japan). Crystal morphology was examined in five randomly selected fields at 100× magnification. 
Images were captured from different fields. The most representative images are shown in Figure 2. 
3.5. Antioxidant Assays 
3.5.1. DPPH Assay  
The DPPH scavenging activity of the samples was measured according to the method described by 
Ye et al. [37]. Briefly, a 0.1 mmol solution of DPPH was prepared in ethanol. Then, a 2.0 mL aliquot 
of the DPPH solution (0.1 mM) was incubated with different concentrations of test samples (each 2.0 mL). 
The reaction mixture was shaken well and incubated for 30 min in the dark, and the absorbance of the 
resulting solution was measured at 517 nm against a blank. Measurements were performed at least in 
triplicate. The percentage of DPPH that was scavenged by the tested extracts was calculated using the 
following formula: 
Scavenging effect = [1 − (Asample − Ablank)/Acontrol)] × 100% 
Here, ethanol (2.0 mL) plus sample solution (2.0 mL) was used as a blank and 2 mL DPPH-ethanol 
solution plus ethanol (2.0 mL) was used as a negative control. 
3.5.2. Superoxide Radical Scavenging Assay 
The ability of SGP to scavenge superoxide anions was measured using a chemiluminescence 
method with a BPCL ultra-weak luminescence analyzer (Institute of Biophysics, Beijing, China). The 
chemiluminescent reaction was conducted in a Na2CO3–NaHCO3 (pH 10.20, 0.5 M) buffer solution. 
Scavenging activity of the samples was evaluated according to their quenching effects on the 
chemiluminescence signal of the luminal-pyrogallol system [38]. The ability to scavenge superoxide 
anion was calculated as follows:  
Scavenging effect = (CLblank − CLsample)/CLblank × 100% 
Here, CLblank and CLsample represent chemiluminescence peak areas of the blank group and test 
group, respectively. The luminous intensity was recorded at 2-s intervals and the total luminous 
integrated intensity was determined for 150 s. 
3.5.3. Reducing Powers of SGP 
Reducing powers of SGP were evaluated by the method described by Sun et al. [38]. Briefly, an 
aliquot (2.0 mL) of each sample (at different concentrations) was mixed with 2.0 mL phosphate buffer 
(0.2 mol/L, pH 6.6) and 2.0 mL potassium ferricyanide (1% w/v). The reaction mixture was incubated 
at 50 °C for 20 min, then 2.5 mL trichloroacetic acid (10% w/v) was added, and then the mixture was 
centrifuged at 22.2 g for 10 min. The supernatant was mixed with 2.5 mL distilled water and 0.5 mL Mar. Drugs 2012, 10 127 
 
 
ferric chloride solution (0.1% w/v), and the absorbance was measured at 700 nm. Increased absorbance 
of the reaction mixture indicated greater reducing power. 
3.6. Statistical Analysis 
All values shown are means ± SD. P-values less than 0.05 were regarded as significant. All 
statistical comparisons between groups were made using one-way analysis of variance with Dunnett’s 
post hoc test or by Student’s t-test. Statistical analyses were carried out using Origin 8 software. 
4. Conclusions  
The ability of urine to inhibit CaOx crystallization is an important mechanism against formation of 
urinary stones. Various physicochemical techniques, including turbidimetry methods, conductometric 
and nephelometric titrations, UV-vis and IR spectroscopy techniques, and potential measurements 
have been used to evaluate crystal formation [8,39]. For the current study, we used a turbidimetry 
method to induce and monitor crystallization because it is rapid and reproducible, and allows 
measurements of nucleation, growth, and aggregation of CaOx crystals [40,41]. We found that SGP 
inhibited CaOx crystal nucleation and aggregation at similar rates as trisodium citrate, a well-known 
inhibitor of CaOx crystallization that is widely used to prevent urinary stones.  
SGP has many negatively charged –OSO3–, –COO–, and –OH groups, and these anions strongly 
coordinate with Ca
2+ ions [42]. The numerous negatively charged groups of SGP were able to chelate 
Ca
2+ ions, resulting in a rapid increase in the concentration of Ca
2+ ions on the surface of the SGP 
molecules. This resulted in a higher energy interface on the surface of SGP molecules. The adsorption 
of Ca
2+ ions would result in a simultaneous decrease in free Ca
2+ ions and an increase in the energy 
state of Ca
2+ ions. Both the high energy interface and high energy state Ca
2+ ions would then promote 
the formation of thermodynamically metastable COD [8].  
Our findings indicate that natural substances such as SGP could contribute to the prevention of 
urinary stones. Sulfated polysaccharides from marine algae possess numerous pharmacological 
properties, but there is little research on sulfated polysaccharides from S. graminifolium. Further studies 
on natural substances should be carried out to assess their effects on CaOx crystallization in vivo. 
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